Brain, Vol. 125, No. 2, 327-337,
February 1, 2002
© 2002 Oxford University Press
Brain atrophy in clinically early relapsingremitting multiple sclerosis
NMR Research Unit, Department of Clinical Neurology, Institute of Neurology, University College London and Imaging Science and Biomedical Engineering, University of Manchester, UK
Correspondence to: Professor D. H. Miller, NMR Research Unit, Institute of Neurology, Queen Square, London WC1N 3BG, UK E-mail: d.miller{at}ion.co.uk
Brain atrophy measured by MRI is a potentially useful tool for monitoring disease progression in multiple sclerosis. The location, extent and mechanisms of brain atrophy in early disease are not well documented. Using quantitative MRI, this study investigated whole brain, grey and white matter atrophy in clinically early relapsingremitting multiple sclerosis and its relationship to lesion measures. Data came from 27 normal control subjects (14 females and 13 males, mean age 36.1 years) and 26 subjects with clinically definite multiple sclerosis (18 females and eight males, mean age 35.1 years, mean delay from first symptom to scan 1.8 years, median Expanded Disability Status Scale score 1.0). All had three-dimensional fast spoiled gradient recall (3D FSPGR), T1-weighted pre- and post-gadolinium-enhanced and T2-weighted scans. The 3D FSPGR images were automatically segmented into grey and white matter and cerebrospinal fluid using SPM99. 3D FSPGR hypo-intense, T2 hyper-intense, T1 hypo-intense and T1 post-gadolinium-enhancing lesion volumes were determined by semi-automatic lesion segmentation. The SPM99 output was combined with the 3D FSPGR lesion segmentations to quantify tissue volumes as fractions of total intracranial volumes, producing values for the brain parenchymal fraction (BPF), white matter fraction (WMF) and grey matter fraction (GMF). Comparing multiple sclerosis with control subjects, BPF, GMF and WMF were significantly reduced (P < 0.001 for all tissue fractions). Using Pearson correlations, T2 hyper-intense and T1 hypo-intense lesion volumes were inversely related to BPF (T2 r = 0.78, P < 0.001; T1 r = 0.59, P = 0.002) and GMF (T2 r = 0.73, P < 0.001; T1 r = 0.53, P = 0.006), but not WMF (T2 r = 0.30, P = 0.134; T1 r = 0.26, P = 0.199). T1 post-gadolinium-enhancing lesion volumes were not correlated with any fractional volumes. These results indicate that significant brain atrophy, affecting both grey and white matter, occurs early in the clinical course of multiple sclerosis. The lack of correlation between lesion load measures and WMF suggests that pathological changes in white matter may occur by mechanisms which are at least partly independent from overt lesion genesis in early multiple sclerosis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Fisniku, D. Altmann, M Cercignani, D. Tozer, D. Chard, J. Jackson, K. Miszkiel, K Schmierer, A. Thompson, and D. Miller Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis Multiple Sclerosis, June 1, 2009; 15(6): 668 - 677. [Abstract] [PDF] |
||||
![]() |
J Furby, T Hayton, D Altmann, R Brenner, J Chataway, K. Smith, D. Miller, and R Kapoor Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis Multiple Sclerosis, June 1, 2009; 15(6): 687 - 694. [Abstract] [PDF] |
||||
![]() |
E. M. Mowry, A. Beheshtian, E. Waubant, D. S. Goodin, B. A. Cree, P. Qualley, R. Lincoln, M. F. George, R. Gomez, S. L. Hauser, et al. Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures Neurology, May 19, 2009; 72(20): 1760 - 1765. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He, A. Dagher, Z. Chen, A. Charil, A. Zijdenbos, K. Worsley, and A. Evans Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load Brain, May 12, 2009; (2009) awp089v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Korteweg, M Rovaris, V Neacsu, M Filippi, G Comi, B. Uitdehaag, D. Knol, C. Polman, F Barkhof, H Vrenken, et al. Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics? Multiple Sclerosis, April 1, 2009; 15(4): 465 - 471. [Abstract] [PDF] |
||||
![]() |
J. Sepulcre, J. Goni, J. C. Masdeu, B. Bejarano, N. Velez de Mendizabal, J. B. Toledo, and P. Villoslada Contribution of White Matter Lesions to Gray Matter Atrophy in Multiple Sclerosis: Evidence From Voxel-Based Analysis of T1 Lesions in the Visual Pathway Arch Neurol, February 1, 2009; 66(2): 173 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Tedeschi, D Dinacci, M Comerci, L Lavorgna, G Savettieri, A Quattrone, P Livrea, F Patti, V Brescia Morra, G Servillo, et al. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study Multiple Sclerosis, February 1, 2009; 15(2): 204 - 211. [Abstract] [PDF] |
||||
![]() |
B. Moraal, D. S. Meier, P. A. Poppe, J. J. G. Geurts, H. Vrenken, W. M. A. Jonker, D. L. Knol, R. A. van Schijndel, P. J. W. Pouwels, C. Pohl, et al. Subtraction MR Images in a Multiple Sclerosis Multicenter Clinical Trial Setting Radiology, February 1, 2009; 250(2): 506 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
R G Henry, M Shieh, D T Okuda, A Evangelista, M L Gorno-Tempini, and D Pelletier Regional grey matter atrophy in clinically isolated syndromes at presentation J. Neurol. Neurosurg. Psychiatry, November 1, 2008; 79(11): 1236 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
X Lin, C R Tench, P S Morgan, and C S Constantinescu Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 437 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Summers, L. Fisniku, V. Anderson, D. Miller, L. Cipolotti, and M. Ron Cognitive impairment in relapsing--remitting multiple sclerosis can be predicted by imaging performed several years earlier Multiple Sclerosis, March 1, 2008; 14(2): 197 - 204. [Abstract] [PDF] |
||||
![]() |
Z Khaleeli, J Sastre-Garriga, O Ciccarelli, D H Miller, and A J Thompson Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1076 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tiwari-Woodruff, L. B. J. Morales, R. Lee, and R. R. Voskuhl Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER){alpha} and ERbeta ligand treatment PNAS, September 11, 2007; 104(37): 14813 - 14818. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.B. Kezele, J.T. Chen, D.L. Arnold, and D.L. Collins The relation of focal white matter signal abnormality and focal volume loss in multiple sclerosis Multiple Sclerosis, July 1, 2007; 13(6): 809 - 813. [Abstract] [PDF] |
||||
![]() |
S. A. Gauthier, M. Mandel, C.R.G. Guttmann, B. I. Glanz, S. J. Khoury, R. A. Betensky, and H. L. Weiner Predicting short-term disability in multiple sclerosis Neurology, June 12, 2007; 68(24): 2059 - 2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-K. Yang, K.-C. Wong, M.-Y. Wu, S.-L. Liao, C.-S. Kuo, and R.-F. S. Huang Correlations Between Folate, B12, Homocysteine Levels, and Radiological Markers of Neuropathology in Elderly Post-Stroke Patients J. Am. Coll. Nutr., June 1, 2007; 26(3): 272 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Khan Can clinical outcomes be used to detect neuroprotection in multiple sclerosis? Neurology, May 29, 2007; 68(22_suppl_3): S64 - S71. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Audoin, G. Davies, W. Rashid, L. Fisniku, A.J. Thompson, and D.H. Miller Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis Multiple Sclerosis, May 1, 2007; 13(4): 483 - 489. [Abstract] [PDF] |
||||
![]() |
R. Zivadinov, L. Locatelli, D. Cookfair, B. Srinivasaraghavan, A. Bertolotto, M. Ukmar, A. Bratina, C. Maggiore, A. Bosco, A. Grop, et al. I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy Multiple Sclerosis, May 1, 2007; 13(4): 490 - 501. [Abstract] [PDF] |
||||
![]() |
M. Juha, S. Leszek, F. Sten, H. Jan, B. Jakob, F. Olof, and K. W. Maria Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development J. Neurol. Neurosurg. Psychiatry, April 1, 2007; 78(4): 375 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Rashid, G R Davies, D T Chard, C M Griffin, D R Altmann, A J Thompson, and D H Miller Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study Multiple Sclerosis, March 1, 2007; 13(2): 178 - 185. [Abstract] [PDF] |
||||
![]() |
I. Pirko, C. F. Lucchinetti, S. Sriram, and R. Bakshi Gray matter involvement in multiple sclerosis Neurology, February 27, 2007; 68(9): 634 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
J H Simon Brain atrophy in multiple sclerosis: what we know and would like to know Multiple Sclerosis, November 1, 2006; 12(6): 679 - 687. [Abstract] [PDF] |
||||
![]() |
C. Wegner, M. M. Esiri, S. A. Chance, J. Palace, and P. M. Matthews Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology, September 26, 2006; 67(6): 960 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Bieniek, D R Altmann, G R Davies, G T Ingle, W Rashid, J Sastre-Garriga, A J Thompson, and D H Miller Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1036 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sepulcre, J. Sastre-Garriga, M. Cercignani, G. T. Ingle, D. H. Miller, and A. J. Thompson Regional Gray Matter Atrophy in Early Primary Progressive Multiple Sclerosis: A Voxel-Based Morphometry Study. Arch Neurol, August 1, 2006; 63(8): 1175 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. J. Morales, K. K. Loo, H.-b. Liu, C. Peterson, S. Tiwari-Woodruff, and R. R. Voskuhl Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J. Neurosci., June 21, 2006; 26(25): 6823 - 6833. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Audoin, K. T. M. Fernando, J. K. Swanton, A. J. Thompson, G. T. Plant, and D. H. Miller Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis Brain, April 1, 2006; 129(4): 1031 - 1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Sanfilipo, R. H.B. Benedict, B. Weinstock-Guttman, and R. Bakshi Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis Neurology, March 14, 2006; 66(5): 685 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dalton, K. A. Miszkiel, P. W. O'Connor, G. T. Plant, G.P.A. Rice, and D. H. Miller Ventricular enlargement in MS: One-year change at various stages of disease Neurology, March 14, 2006; 66(5): 693 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Richert, T. Howard, J. A. Frank, R. Stone, J. Ostuni, J. Ohayon, C. Bash, and H. F. McFarland Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis Neurology, February 28, 2006; 66(4): 551 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Rashid, G R Davies, D T Chard, C M Griffin, D R Altmann, R Gordon, A J Thompson, and D H Miller Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 51 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. T. M. Fernando, D. J. Tozer, K. A. Miszkiel, R. M. Gordon, J. K. Swanton, C. M. Dalton, G. J. Barker, G. T. Plant, A. J. Thompson, and D. H. Miller Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis Brain, December 1, 2005; 128(12): 2911 - 2925. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bermel, S. R. Puli, R. A. Rudick, B. Weinstock-Guttman, E. Fisher, F. E. Munschauer III, and R. Bakshi Prediction of Longitudinal Brain Atrophy in Multiple Sclerosis by Gray Matter Magnetic Resonance Imaging T2 Hypointensity Arch Neurol, September 1, 2005; 62(9): 1371 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tedeschi, L. Lavorgna, P. Russo, A. Prinster, D. Dinacci, G. Savettieri, A. Quattrone, P. Livrea, C. Messina, A. Reggio, et al. Brain atrophy and lesion load in a large population of patients with multiple sclerosis Neurology, July 26, 2005; 65(2): 280 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
G R Davies, D R Altmann, W Rashid, D T Chard, C M Griffin, G J Barker, R Kapoor, A J Thompson, and D H Miller Emergence of thalamic magnetization transfer ratio abnormality in early relapsing--remitting multiple sclerosis Multiple Sclerosis, June 1, 2005; 11(3): 276 - 281. [Abstract] [PDF] |
||||
![]() |
J. Sastre-Garriga, G. T. Ingle, D. T. Chard, M. Cercignani, L. Ramio-Torrenta, D. H. Miller, and A. J. Thompson Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study Brain, June 1, 2005; 128(6): 1454 - 1460. [Abstract] [Full Text] [PDF] |
||||
![]() |
M S A Deloire, E Salort, M Bonnet, Y Arimone, M Boudineau, H Amieva, B Barroso, J-C Ouallet, C Pachai, E Galliaud, et al. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 519 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Versijpt, J C Debruyne, K J Van Laere, F De Vos, J Keppens, K Strijckmans, E Achten, G Slegers, R A Dierckx, J Korf, et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study Multiple Sclerosis, April 1, 2005; 11(2): 127 - 134. [Abstract] [PDF] |
||||
![]() |
M. Tiberio, D. T. Chard, D. R. Altmann, G. Davies, C. M. Griffin, W. Rashid, J. Sastre-Garriga, A. J. Thompson, and D. H. Miller Gray and white matter volume changes in early RRMS: A 2-year longitudinal study Neurology, March 22, 2005; 64(6): 1001 - 1007. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pagani, M. A. Rocca, A. Gallo, M. Rovaris, V. Martinelli, G. Comi, and M. Filippi Regional Brain Atrophy Evolves Differently in Patients with Multiple Sclerosis According to Clinical Phenotype AJNR Am. J. Neuroradiol., February 1, 2005; 26(2): 341 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Ranjeva, B. Audoin, M. Van Au Duong, D. Ibarrola, S. Confort-Gouny, I. Malikova, E. Soulier, P. Viout, A. Ali-Cherif, J. Pelletier, et al. Local Tissue Damage Assessed with Statistical Mapping Analysis of Brain Magnetization Transfer Ratio: Relationship with Functional Status of Patients in the Earliest Stage of Multiple Sclerosis AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bakshi, G. J. Hutton, J. R. Miller, and E.-W. Radue The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis Neurology, December 14, 2004; 63(11_suppl_5): S3 - S11. [Abstract] [Full Text] |
||||
![]() |
L. Locatelli, R. Zivadinov, A. Grop, and M. Zorzon Frontal parenchymal atrophy measures in multiple sclerosis Multiple Sclerosis, October 1, 2004; 10(5): 562 - 568. [Abstract] [PDF] |
||||
![]() |
D T Chard, C M Griffin, W Rashid, G R Davies, D R Altmann, R Kapoor, G J Barker, A J Thompson, and D H Miller Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis Multiple Sclerosis, August 1, 2004; 10(4): 387 - 391. [Abstract] [PDF] |
||||
![]() |
M. P. Amato, M. L. Bartolozzi, V. Zipoli, E. Portaccio, M. Mortilla, L. Guidi, G. Siracusa, S. Sorbi, A. Federico, and N. De Stefano Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment Neurology, July 13, 2004; 63(1): 89 - 93. [Abstract] [Full Text] [PDF] |
||||
![]() |
G R Davies, L Ramio-Torrenta, A Hadjiprocopis, D T Chard, C M B Griffin, W Rashid, G J Barker, R Kapoor, A J Thompson, and D H Miller Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis J. Neurol. Neurosurg. Psychiatry, July 1, 2004; 75(7): 998 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sharma, M. P. Sanfilipo, R. H. B. Benedict, B. Weinstock-Guttman, F. E. Munschauer III, and R. Bakshi Whole-Brain Atrophy in Multiple Sclerosis Measured by Automated versus Semiautomated MR Imaging Segmentation AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 985 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Dalton, D. T. Chard, G. R. Davies, K. A. Miszkiel, D. R. Altmann, K. Fernando, G. T. Plant, A. J. Thompson, and D. H. Miller Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes Brain, May 1, 2004; 127(5): 1101 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ge, O. Gonen, M. Inglese, J. S. Babb, C. E. Markowitz, and R. I. Grossman Neuronal cell injury precedes brain atrophy in multiple sclerosis Neurology, February 24, 2004; 62(4): 624 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Rashid, A Hadjiprocopis, C M Griffin, D T Chard, G R Davies, G J Barker, P S Tofts, A J Thompson, and D H Miller Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction Multiple Sclerosis, February 1, 2004; 10(1): 9 - 15. [Abstract] [PDF] |
||||
![]() |
C. Malmestrom, S. Haghighi, L. Rosengren, O. Andersen, and J. Lycke Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS Neurology, December 23, 2003; 61(12): 1720 - 1725. [Abstract] [Full Text] [PDF] |
||||
![]() |
D T Chard, P A Brex, O Ciccarelli, C M Griffin, G J M Parker, C Dalton, D R Altmann, A J Thompson, and D H Miller The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study J. Neurol. Neurosurg. Psychiatry, November 1, 2003; 74(11): 1551 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Juengling, J. Kassubek, and Y. Ge Standardized Calculation of Brain Parenchymal Fraction: An Approach to Objective Assessment of Cerebral Atrophy AJNR Am. J. Neuroradiol., August 1, 2003; 24(7): 1492 - 1493. [Full Text] [PDF] |
||||
![]() |
C. Wegner and P.M. Matthews A new view of the cortex, new insights into multiple sclerosis Brain, August 1, 2003; 126(8): 1719 - 1721. [Full Text] [PDF] |
||||
![]() |
M. Sailer, B. Fischl, D. Salat, C. Tempelmann, M. A. Schonfeld, E. Busa, N. Bodammer, H.-J. Heinze, and A. Dale Focal thinning of the cerebral cortex in multiple sclerosis Brain, August 1, 2003; 126(8): 1734 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wylezinska, A. Cifelli, P. Jezzard, J. Palace, M. Alecci, and P. M. Matthews Thalamic neurodegeneration in relapsing-remitting multiple sclerosis Neurology, June 24, 2003; 60(12): 1949 - 1954. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. De Stefano, P. M. Matthews, M. Filippi, F. Agosta, M. De Luca, M. L. Bartolozzi, L. Guidi, A. Ghezzi, E. Montanari, A. Cifelli, et al. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability Neurology, April 8, 2003; 60(7): 1157 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rudick Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis? Multiple Sclerosis, April 1, 2003; 9(2): 210 - 212. [PDF] |
||||
![]() |
M. Rovaris, M. A Rocca, and M. Filippi Magnetic resonance-based techniques for the study and management of multiple sclerosis Br. Med. Bull., March 1, 2003; 65(1): 133 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.J. Eikelenboom, A. Petzold, R.H.C. Lazeron, E. Silber, M. Sharief, E.J. Thompson, F. Barkhof, G. Giovannoni, C.H. Polman, and B.M.J. Uitdehaag Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy Neurology, January 28, 2003; 60(2): 219 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Chard, C. M. Griffin, M. A. McLean, P. Kapeller, R. Kapoor, A. J. Thompson, and D. H. Miller Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis Brain, October 1, 2002; 125(10): 2342 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Miller, F. Barkhof, J. A. Frank, G. J. M. Parker, and A. J. Thompson Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance Brain, August 1, 2002; 125(8): 1676 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Brain Atrophy Occurs Earlier Than Expected in MS Journal Watch Neurology, May 10, 2002; 2002(510): 1 - 1. [Full Text] |
||||











